尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Chrousos Phaedra, Directrice. Director active across 1 company, notably Vanda Pharmaceuticals Inc.. Aggregated, 7 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €33k. Activity tracked since 10 June 2021. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Phaedra Chrousos is a Director at Vanda Pharmaceuticals Inc. She contributes to corporate governance and strategy for the company. As a board member, she participates in strategic decision-making that influences Vanda's direction. Her expertise in the pharmaceutical sector allows her to make significant contributions.